Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Wendeler

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The FEBS Journal|February 16, 2006
The enzyme-binding region of human GM2-activator proteinMichaela Wendeler, Norbert Werth, Timm Maier, et al.
RNA (New York, N.Y.)|July 15, 2011
Correlating SHAPE signatures with three-dimensional RNA structuresEckart Bindewald, Michaela Wendeler, Michal Legiewicz, et al.
Biotechnology Progress|August 21, 2014
Development and scale-up of a commercial fed batch refolding process for an anti-CD22 two chain immunotoxinThomas Linke, Matthew T Aspelund, Christopher Thompson, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease HSuhman Chung, Michaela Wendeler, Jason W Rausch, et al.
ACS Chemical Biology|October 4, 2008
Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activityMichaela Wendeler, Hsiu-Fang Lee, Alun Bermingham, et al.
Plos One|December 22, 2016
A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development PropertiesAndrew C Nyborg, Chris Ward, Anna Zacco, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The FEBS Journal|February 16, 2006
The enzyme-binding region of human GM2-activator proteinMichaela Wendeler, Norbert Werth, Timm Maier, et al.
RNA (New York, N.Y.)|July 15, 2011
Correlating SHAPE signatures with three-dimensional RNA structuresEckart Bindewald, Michaela Wendeler, Michal Legiewicz, et al.
Biotechnology Progress|August 21, 2014
Development and scale-up of a commercial fed batch refolding process for an anti-CD22 two chain immunotoxinThomas Linke, Matthew T Aspelund, Christopher Thompson, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease HSuhman Chung, Michaela Wendeler, Jason W Rausch, et al.
ACS Chemical Biology|October 4, 2008
Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activityMichaela Wendeler, Hsiu-Fang Lee, Alun Bermingham, et al.
Plos One|December 22, 2016
A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development PropertiesAndrew C Nyborg, Chris Ward, Anna Zacco, et al.
Pageof 4